Donna Mabry‐Hrones

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Immune Checkpoint Blockade in Combination with Stereotactic Body Radiotherapy in Patients with Metastatic Pancreatic Ductal Adenocarcinoma”.

Immune Checkpoint Blockade in Combination with Stereotactic Body Radiotherapy in Patients with Metastatic Pancreatic Ductal Adenocarcinoma

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3624

N/A

0DataRank · unranked

101 citations

Austin G. Duffy, Gagandeep Brar, Suzanne Fioravanti, Donna Mabry‐Hrones, Melissa Walker +14 more

A phase I/II study of Pexa-Vec oncolytic virus in combination with immune checkpoint inhibition in refractory colorectal cancer.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.4_suppl.117

N/A

0DataRank · unranked

19 citations

Changqing Xie, Seth M. Steinberg, Suzanne Fioraventi, Melissa Walker, Donna Mabry‐Hrones +4 more

Phase II study of nivolumab (anti-PD1), tadalafil, and oral vancomycin in patients with refractory primary hepatocellular carcinoma or liver dominant metastatic cancer from colorectal or pancreatic cancers.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.tps4656

N/A

0DataRank · unranked

4 citations

Changqing Xie, Donna Mabry‐Hrones, Bradford J. Wood, Seth M. Steinberg, David E. Kleiner +2 more

Long-term survival of combined ablation therapy and tremelimumab with or without durvalumab in advanced hepatocellular carcinoma.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.e16689

N/A

0DataRank · unranked

1 citations

Changqing Xie, John C. McVey, Donna Mabry‐Hrones, Austin G. Duffy, Bradford J. Wood +2 more

Perioperative MVT-5873, a fully human monoclonal antibody against a CA 19-9 epitope, for operable CA 19-9 producing pancreatic cancers, cholangiocarcinomas, and metastatic colorectal cancers.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.tps4655

N/A

0DataRank · unranked

1 citations

James D. McDonald, Reed I. Ayabe, Tahsin M. Khan, Lauren A. Gamble, Alexander J. Rossi +9 more

A phase I study of GPC3 targeted CAR-T cell therapy in advanced GPC3-expressing hepatocellular carcinoma (HCC).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.tps624

N/A

0DataRank · unranked

18 citations

M. Cecilia Monge B., Donna Mabry‐Hrones, Kelley Coffman, Stephanie N. Hicks, Bernadette Redd +5 more